SCHEMBL7242539

SCHEMBL7242539

CCOC(=O)c1sc(Oc2ccc(C(C)=O)c(OC)c2)c2c1CCc1cnn(C)c1-2

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCNC P24863 9/20 0.50
CDK8 P49336 9/20 0.50
CDK19 Q9BWU1 9/20 0.50
MAPT P10636 4/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
DRD2 P14416 1/20 0.37
DRD4 P21917 1/20 0.37
CCNA2 P20248 1/20 0.37
CDK2 P24941 1/20 0.37
CCNA1 P78396 1/20 0.37
ALDH1A1 P00352 4/20 0.35
KDM4E B2RXH2 3/20 0.35
PKM P14618 2/20 0.35
LMNA P02545 2/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
ABCC1 P33527 1/20 0.34
ABCG2 Q9UNQ0 1/20 0.34
HPGD P15428 2/20 0.34
GAA P10253 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7245561 0.92 CCNC (0.55) CCNCCDK8CDK19MAPTSMN1; SMN2
SCHEMBL7242876 0.90 CCNC (0.49) CCNCCDK8CDK19MAPTSMN1; SMN2
SCHEMBL7251482 0.89 CCNC (0.46) CCNCCDK8CDK19MAPTSMN1; SMN2
SCHEMBL7250980 0.89 CCNC (0.51) CCNCCDK8CDK19DRD2DRD4
SCHEMBL7248522 0.88 CCNC (0.62) CCNCCDK8CDK19CDK9MAP3K19
SCHEMBL7242865 0.86 CCNC (0.54) CCNCCDK8CDK19MAPTSMN1; SMN2
SCHEMBL7249230 0.84 CCNC (0.55) CCNCCDK8CDK19MAPTSMN1; SMN2
SCHEMBL7038710 0.83 CCNC (0.54) CCNCCDK8CDK19MAPTSMN1; SMN2
SCHEMBL7248569 0.83 CCNC (0.56) CCNCCDK8CDK19MAPTSMN1; SMN2
SCHEMBL7244945 0.83 CCNC (0.54) CCNCCDK8CDK19MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030158245-A1 Fused heterocyclic derivatives, their production and use TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2003-08-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030158245-A1 Fused heterocyclic derivatives, their production and use TST, STS, AHR CCNC 2012/4885CDK8 3614/4885CDK19 2184/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.